2023 Microbiome Market Trends Report 2023: Market is Successfully Commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for Recurrent Clostridium Difficile Infection
/PRNewswire/ -- The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.coms offering. The microbiome therapeutics market is...
United States United Kingdom Yakult Honsha Laura Wood Evelo Biosciences Technology Platform Overview
Source: prnewswire.com